2 Methods A literature search was conducted to identify published evidence that have
evaluated the outcomes of PrEP‐related projects in the Asia‐Pacific. We examined the …

Background Considerable evidence on the costs and cost-effectiveness of biomedical, non-
surgical interventions to prevent human immunodeficiency virus (HIV) transmission has …

Introduction: Research has begun to examine human immunodeficiency virus (HIV)
prevention strategies within the Ghanaian context. Still, little is known about specific …

Objectives To investigate the extent to which articles of economic evaluations of healthcare
interventions indexed in MEDLINE incorporate research practices that promote …

Human immunodeficiency virus (HIV) sexual transmission among men who have sex with
men (MSM) has increased markedly in Beijing, China in the past decade. Pre-exposure …

Introduction More than 70% of new HIV infections in Asia occurred in eight countries in
2020: Cambodia, China, India, Indonesia, Myanmar, Nepal, Thailand, and Vietnam—with a …

Introduction Long‐acting injectable cabotegravir (CAB‐LA) demonstrated superiority to daily
tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for HIV pre‐exposure prophylaxis …

HIV pre-exposure prophylaxis (PrEP) should be free across Canada for all those who meet
evidence-based guidelines. PrEP is a highly effective tool for preventing HIV acquisition that …

Pre-exposure prophylaxis (PrEP) is an efficacious strategy for reducing the incidence of HIV
infection. It has been available in Spain since 2019. We aim to report on awareness …

The negative effects of stigma on men living with HIV within gay communities are well-
documented. However, few studies have examined the experience of intimacy for men living …